)
Visual31 Oct 2025
Three decades of Rolls-Royce
Swedish Orphan Biovitrum (SOBI) investor relations material
Swedish Orphan Biovitrum Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary20 Oct, 2025
Executive summary
Achieved 21% revenue growth at constant currency in Q3 2025, driven by a 39% increase in the strategic growth portfolio and strong commercial execution.
Adjusted EBITDA/EBITA margin reached 47%, reflecting robust business momentum and disciplined cost control.
Upgraded guidance for both sales and EBITDA/EBITA for the full year 2025 due to strong performance and pipeline progress.
Significant pipeline milestones, including regulatory progress for NASP, DOPTELET, and Tryngolza (olezarsen), and FDA acceptance of BLA for NASP.
Non-cash impairment of Vonjo/Bonjour by SEK 6.6 billion due to competitive pressures and lower-than-expected sales, with future growth initiatives underway.
Financial highlights
Q3 total revenue was SEK 7,776 million, up 21% year-over-year at constant currency.
Adjusted gross margin was 80% in Q3 2025, with positive mix effects offset by lower Beyfortus royalties.
Adjusted EBITDA/EBITA was SEK 3,672–3,700 million (47% margin), up from 43% last year.
Adjusted EPS before dilution grew 40% in Q3, excluding impairment and one-off items.
Operating cash flow was SEK 1,840 million, up from SEK 1,201 million last year.
Outlook and guidance
Upgraded 2025 revenue guidance to low double-digit percentage growth at constant currency.
Adjusted EBITDA/EBITA margin guidance raised to mid to high 30s percent of revenue.
Continued growth expected in Q4, especially from Altuvoct, DOPTELET, and Gamifant.
Operating expenses expected to increase in Q4 due to launch investments and R&D.
Vonjo's path to long-term growth after impairment
What factors caused Beyfortus royalty decline?
Tryngolza MCS market potential and launch strategy
Vonjo label expansion strategy
Gamifant sepsis trial: Phase III decision criteria?
Tryngolza EU5 peak sales drivers
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Swedish Orphan Biovitrum earnings date
Q4 20255 Feb, 2026
Next Swedish Orphan Biovitrum earnings date
Q4 20255 Feb, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Swedish Orphan Biovitrum AB, an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. The company operates through three segments: Haemophilia & Hereditary Diseases, Inflammation & Immunology, and Other. It offers Alprolix for hemophilia B; Elocta to treat hemophilia A; Doptelet for thrombocytopenia; Kineret for rheumatoid arthritis; Thiola for cystinuria; Xultophy Cartridge that is used with Flexpen for treatment of diabetes; and Velphoro for hyperphosphatemia.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage